Which of the following is the true action of pralidoxime on cholinesterase enzyme?
**Core Concept**
Pralidoxime is a cholinesterase reactivator that plays a crucial role in the management of organophosphate poisoning. It works by reactivating the acetylcholinesterase enzyme, which is inactivated by organophosphate compounds. This enzyme is essential for the breakdown of acetylcholine, a neurotransmitter that, when accumulated, can lead to severe cholinergic toxicity.
**Why the Correct Answer is Right**
Pralidoxime specifically targets the phosphonylated acetylcholinesterase enzyme, which is formed when organophosphate compounds bind to the enzyme's active site. By breaking the covalent bond between the enzyme and the organophosphate, pralidoxime restores the enzyme's activity, allowing it to hydrolyze acetylcholine and terminate its action on nicotinic and muscarinic receptors. This is a critical mechanism in reversing the life-threatening effects of organophosphate poisoning.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect as pralidoxime does not inhibit the acetylcholinesterase enzyme; rather, it reactivates the enzyme that has been inactivated by organophosphate compounds.
**Option B:** This option is incorrect as pralidoxime does not directly stimulate the release of acetylcholine; its primary action is on the acetylcholinesterase enzyme.
**Option C:** This option is incorrect as pralidoxime does not act as an anticholinesterase agent; it is a cholinesterase reactivator.
**Clinical Pearl / High-Yield Fact**
Pralidoxime should be administered promptly after organophosphate exposure, ideally within 2-3 hours, to maximize its effectiveness in reactivating the acetylcholinesterase enzyme.
**Correct Answer: C. Pralidoxime reactivates the acetylcholinesterase enzyme by breaking the covalent bond between the enzyme and the organophosphate compound.**